Ceftriaxone's Effectiveness Against Diarrhea-Causing Organisms

Bacterial Pathogens Effectively Treated with Ceftriaxone

Ceftriaxone (2g IV daily) plus ciprofloxacin is recommended for bacteremia caused by nontyphoidal Salmonella species 1, 2
For Yersinia bacteremia, ceftriaxone (2g IV daily) plus gentamicin (5 mg/kg IV daily) is the recommended treatment 1, 2, 3
Ceftriaxone may be used in severe cases or bacteremia of diarrhea caused by Yersinia 1

The Infectious Diseases Society of America recommends empiric antibacterial treatment with ceftriaxone in immunocompromised patients with severe illness and bloody diarrhea 4
The Infectious Diseases Society of America recommends empiric antibacterial treatment with ceftriaxone in infants under 3 months of age with suspected bacterial diarrhea 4
The Infectious Diseases Society of America recommends empiric antibacterial treatment with ceftriaxone in patients with signs of sepsis or bacteremia 1, 4
Ceftriaxone is particularly valuable for severe infections or in immunocompromised hosts 4

Viral causes of diarrhea (norovirus, rotavirus, adenovirus) do not respond to ceftriaxone 1, 2
Ceftriaxone is not effective against parasitic causes of diarrhea such as Giardia, Cryptosporidium, or Cyclospora 4
For Campylobacter species, azithromycin is preferred as first-line therapy, with fluoroquinolones as alternatives; ceftriaxone is not specifically recommended for Campylobacter diarrhea 1, 2, 3

The clinical guidelines for infectious diseases do not recommend the ceftriaxone‑sulbactam combination for the treatment of acute gastroenteritis; they specify ceftriaxone monotherapy (or ceftriaxone + metronidazole) only for complicated intra‑abdominal infections, not for enteric pathogens. [5][6]7

Combining ceftriaxone with sulbactam for acute gastroenteritis is inappropriate because this regimen is intended for intra‑abdominal infections with anaerobic coverage, not for enteric bacterial pathogens. [8][5]7